Navigation Links
Narrowest bridges of gold are also the strongest, study finds
Date:7/13/2011

BUFFALO, N.Y. -- At an atomic scale, the tiniest bridge of gold -- that made of a single atom -- is actually the strongest, according to new research by engineers at the University at Buffalo's Laboratory for Quantum Devices.

The counterintuitive finding is the result of experiments probing the characteristics of atomic-scale necks of gold that formed when the pointed, gold tip of a cantilever was pushed into a flat, gold surface. An examination of these tiny, gold bridges revealed that they were stiffest when they comprised just a single atom.

The study was published in June in Physical Review B by a trio of UB researchers: postdoctoral fellow Jason Armstrong and professors Susan Hua and Harsh Deep Chopra, all in UB's Department of Mechanical and Aerospace Engineering. Support for the work came from National Science Foundation grants No. DMR-0706074 and No. DMR-0964830.

As engineers look to build devices such as computer circuits with ever-smaller parts, it is critical to learn more about how tiny components comprising a single atom or a few atoms might behave. The physical properties of atomic-scale gadgets differ from those of larger, "bulk" counterparts.

"Everyday intuition would suggest that devices made of just a few atoms would be highly susceptible to mechanical forces," the team said. "This study finds, however, that the ability of the material to resist elastic deformation actually increases with decreasing size."

Another observation the team made while studying the tiny gold necks: abrupt atomic displacements that occur as the gold tip and surface are drawn apart are not arbitrary, but follow well-defined rules of crystallography. More scientific highlights of the work are summarized in the Physical Review Focus of the American Physical Society at http://focus.aps.org/story/v27/st24.

UB's Laboratory for Quantum Devices, led by Chopra and Hua, works on mapping the evolution of various physical properties of materials -- including mechanical, magnetic and magneto-transport behavior -- as sample sizes grow from a single atom to bulk.

This complicated task requires technology capable of capturing a single or few atoms between probes, and further pushing and pulling on the atoms to study their response.

The sophisticated technology that Armstrong, Hua and Chopra invented and built to accomplish the research was recently licensed to Precision Scientific Instruments Inc., a Western New York start-up company founded by the leaders of Murak & Associates LLC, a management consulting practice; SoPark Corporation, an electronics service manufacturer (ESM); and The PCA Group, Inc., a consulting firm that offers total technology solutions.

"The instruments and methods are incredibly precise and capable of deforming the sample at the picometer scale (about 100 times smaller than an atom), which means literally stretching the bond lengths, and simultaneously measuring the forces at the piconewton level, as well as various other properties. As a very broad perspective, by enabling researchers to probe the very small, the technology could speed advances in fields ranging from satellite communications to health care," said Gerry Murak, president and cofounder of Precision Scientific Instruments, Inc.

"Small is exciting, and atomic scale devices are the new frontier of technology. Metrology systems capable of probing the behavior of atomic-scale devices are sorely needed, and this technology gives us a unique platform," Murak said.


'/>"/>

Contact: Charlotte Hsu
chsu22@buffalo.edu
716-645-4655
University at Buffalo
Source:Eurekalert  

Related biology technology :

1. Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace
2. Virginia Tech engineers investigate energy independent monitoring system for bridges
3. Chimerix Commences Phase 2 Clinical Study of CMX001 for Prevention of Adenovirus Disease in Pediatric and Adult Hematopoietic Stem Cell Transplant Patients
4. University of Dayton Study Overturns 250-Year-Old Belief About Effects of Age, Repeated Injury on Tissue Regeneration
5. InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF
6. Inovio Pharmaceuticals DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study
7. Intarcia Presents Positive Phase 2 48-week Results From ITCA 650 Study at the American Diabetes Association 71st Scientific Sessions
8. New study: Even in flies, enriched learning drives need for sleep
9. Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of AC-201 for the Treatment of Type II Diabetes
10. Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma
11. Adeona Announces Positive Alzheimers Subgroup Analysis that Supports Additional Clinical Study of Proprietary Zinc-Based Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Narrowest bridges of gold are also the strongest, study finds
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):